The most common misunderstanding about the UK medical device route is that it’s one process producing one certificate. It isn’t. It’s three independent requirements that all have to be satisfied, and a manufacturer holding two of the three holds nothing that permits sale.
Placing a medical device on the Great Britain market requires three separate things, and none of them substitutes for another. First, conformity assessment under UK MDR 2002 — for higher-risk classes this means a UK Approved Body, designated by the MHRA, reviewing technical documentation and auditing the quality system before issuing a certificate. EU Notified Bodies cannot issue UKCA certificates, even where the same corporate group operates on both sides. Second, registration with the MHRA through its Device Online Registration System, which is a separate mandatory step — a device cannot be legally placed on the GB market until registered, regardless of what certificates exist. Third, for manufacturers based outside the UK, appointment of a UK Responsible Person, whose name and address appear on the labelling for UKCA-marked devices. Holding a UKCA certificate without MHRA registration means the device cannot be sold; holding registration without the underlying conformity assessment means the same. They are cumulative, not alternative — which is the structural point worth understanding before reading anyone’s claim about UK approval.
§01Three requirements, not three stages
The word “stages” would imply a sequence where completing one moves you toward the next. That’s partly true operationally, but it misdescribes the legal position: these are three independent conditions, each of which must hold at the moment of placing the device on the market.
Devices are assessed against UK MDR 2002. For classes above the lowest risk tier, this requires third-party assessment: a UK Approved Body designated by the MHRA reviews the technical documentation and audits the quality management system, then issues a certificate. The manufacturer issues a Declaration of Conformity and applies the UKCA mark.
The detail that catches people: EU Notified Bodies cannot issue UKCA certificates. Many EU bodies operate UK subsidiaries, and the legal entity on the certificate is what matters — a certificate from the EU arm of a group whose UK arm is designated does not satisfy the UK requirement.
WHAT IT PRODUCES: a certificate from a specific named UK entity, verifiable against the MHRA’s register of Approved Bodies.All medical devices must be registered with the MHRA through the Device Online Registration System (DORS) before being placed on the Great Britain market. This is not a formality that follows automatically from certification; it’s a distinct obligation with its own submission.
The practical consequence is worth stating directly: a device holding a valid UKCA certificate but not registered in DORS cannot legally be placed on the GB market. The certificate establishes conformity; the registration establishes that the regulator knows the device exists and who is responsible for it.
WHAT IT PRODUCES: a registration record with the MHRA, which is the step most likely to be assumed rather than completed.A manufacturer based outside the UK must appoint a UK Responsible Person to act on its behalf and liaise with the MHRA. For UKCA-marked devices, the UKRP’s name and address must appear on the labelling.
This is structurally similar to the local-entity requirements that appear across many markets — a regulator wants someone inside its jurisdiction who is answerable. The same pattern appears in emerging market certification, where the local entity requirement is often the binding constraint rather than the technical testing.
WHAT IT PRODUCES: a named UK entity on the label, and an ongoing relationship that has to be maintained rather than obtained once.FIG.01 — Cumulative, not alternative. The middle box is the one most frequently overlooked, because certification feels like the hard part and registration feels administrative — but the legal effect of missing it is identical.
§02How this differs from a US clearance
Worth comparing directly, since the two are often spoken about as though they were equivalent achievements.
| Dimension | United States | Great Britain |
|---|---|---|
| WHO ASSESSES | The FDA itself reviews the premarket submission | A UK Approved Body — a designated third party, not the regulator |
| WHAT’S PRODUCED | A clearance or approval decision, published in a searchable database | A certificate from the Approved Body, plus a manufacturer’s own Declaration of Conformity |
| REGISTRATION | Establishment registration and device listing, separate from clearance | MHRA registration via DORS, separate from certification |
| LOCAL ENTITY | US agent required for foreign establishments | UK Responsible Person, named on UKCA labelling |
| QMS | Quality system requirements apply | Quality management system audited as part of third-party assessment, typically ISO 13485 |
TABLE.01 — Structurally similar in what they demand, different in who does the assessing. Note that both jurisdictions separate registration from assessment — a pattern worth remembering, since it’s the source of the most common confusion in regulatory terminology.
§03The transitional situation, and why dates matter here
The practical reading: anything you find about UK medical device requirements should be checked for date, because this framework has genuinely changed several times since 2021 and further change has been signalled. The MHRA’s own guidance is the source worth reading rather than any secondary summary, this one included.
§04Why this route is being taken for infant monitoring
A pattern worth naming, without reference to any specific company. Where a product claims to monitor a physiological parameter, the medical route stops being optional in markets whose definitions capture that claim. A manufacturer wanting to make such a claim in Great Britain therefore faces the three requirements above.
What follows from that is the documentation difference covered in the previous article: a device that has been through this route carries an instructions-for-use document with a stated intended purpose, a defined patient population, and contraindications — which is considerably more specific information than a consumer-positioned equivalent is required to publish. That specificity is a by-product of the regulatory route, not a marketing choice, and it’s the subject of the next article.
§05Reading a UK compliance claim
- “UKCA certified” with no certificate holder named. The issuing body is a specific legal entity and should be identifiable.
- A certificate from an EU Notified Body presented as satisfying UKCA. The UK arm and the EU arm of the same group are different legal entities for this purpose.
- Certification mentioned with no reference to MHRA registration. These are separate obligations and both are required.
- No UK Responsible Person named on labelling for a UKCA-marked device from a non-UK manufacturer.
- “UK approved” as a phrase — not a defined term, and worth asking what specifically is meant.
- A claim citing guidance from several years ago without acknowledging that the framework has changed since.
- UK status presented as establishing anything about EU status. UKCA is not accepted in the EU, and the two routes are separate.
The general discipline for checking that any certificate covers the exact product in front of you is in the document verification checklist — the four bounds it describes (product, holder, time, scope) apply here as much as to any other market.
§06Where True Bond sits
Our products are consumer electronics in the UK as everywhere else. They don’t claim to monitor any physiological parameter, so the medical route doesn’t apply to them, and we hold no UKCA medical device certificate or MHRA registration.
What applies instead is the consumer electronics path — radio, electrical safety and materials compliance for the UK market, which is a genuinely different and narrower set of obligations. We’d rather state that plainly than let “UK compliant” sit in a sentence where a reader might take it to mean something it doesn’t. For brands considering a product with physiological monitoring claims, the three requirements above are the starting point, and they’re a project rather than a certificate — worth scoping properly during product definition rather than discovering after a design is frozen.
§07Frequently asked questions
What is UKCA marking for medical devices?
UKCA is the conformity marking for devices placed on the Great Britain market, operating under UK MDR 2002 and enforced by the MHRA. For device classes above the lowest risk tier, applying it requires conformity assessment by a UK Approved Body — designated by the MHRA — which reviews technical documentation and audits the quality management system before issuing a certificate. The manufacturer then issues a Declaration of Conformity. The mark alone does not permit sale; registration with the MHRA is a separate requirement.
Is a UKCA certificate enough to sell a medical device in the UK?
No. Three things are required and none substitutes for another: conformity assessment under UK MDR 2002 (via a UK Approved Body for higher-risk classes), registration with the MHRA through its Device Online Registration System, and — for manufacturers based outside the UK — appointment of a UK Responsible Person whose details appear on UKCA labelling. A device holding a valid certificate but not registered in DORS cannot legally be placed on the GB market. The requirements are cumulative.
Can an EU Notified Body issue a UKCA certificate?
No. Only UK Approved Bodies designated by the MHRA can issue UKCA certificates. This catches people out because many EU Notified Bodies operate UK subsidiaries within the same corporate group — and the legal entity named on the certificate is what matters. A certificate issued by the EU arm does not satisfy the UK requirement even where the UK arm of the same group is designated, so confirming the exact issuing entity against the MHRA’s register is worth doing.
What is a UK Responsible Person?
A UK-based entity appointed by a manufacturer located outside the UK, acting on its behalf and liaising with the MHRA. For UKCA-marked devices, the UKRP’s name and address must appear on the labelling. This is structurally similar to local-representative requirements found in many other markets: the regulator wants someone inside its jurisdiction who is answerable for the device. It’s an ongoing relationship to be maintained rather than a one-time approval.
How does the UK route differ from FDA clearance?
Mainly in who performs the assessment. In the US the FDA itself reviews the premarket submission and issues a clearance or approval decision. In Great Britain a designated third party — a UK Approved Body — performs the conformity assessment and issues a certificate, with the manufacturer issuing its own Declaration of Conformity. Both jurisdictions separately require registration and a local entity for foreign manufacturers, which is the structural similarity worth noting: in neither market does assessment alone permit sale.
Does True Bond hold UKCA medical device certification?
No. Our products are consumer electronics in the UK as in every other market — they don’t claim to monitor any physiological parameter, so the medical device route doesn’t apply and we hold no UKCA medical device certificate or MHRA registration. What applies instead is the consumer electronics path: radio, electrical safety and materials compliance for the UK market, which is a genuinely different and narrower set of obligations than the medical route described here.
If a project involves physiological claims, scope it before the design freezes
The UK route is three requirements and an ongoing relationship, not a certificate. We can tell you plainly what our current products are and aren’t certified for — and where a claim would change the regulatory picture entirely.
Discuss market requirements → info@truebondtech.com · WhatsApp +86 189 2846 4489 · View productsThis series